“The concept of anti-ageing should, therefore, include youth preservation as part of its objective”
BioSpectrum Asia|BioSpectrum Asia August 2022
Operating in approximately 50 markets worldwide in the Americas, Asia, Europe, Africa and the Pacific, Nu Skin is revolutionising the industry with products that offer comprehensive anti-ageing concerns. By targeting the ultimate sources of ageing, Nu Skin’s ageLOC products dramatically diminish the appearance of ageing. Backed by more than 35 years of scientific research, Nu Skin develops innovative products including Nu Skin personal care, Pharmanex nutrition and the ageLOC anti-ageing brand, which includes an award-winning line of beauty device systems. To find out more about the company’s expertise in the area of anti-ageing, BioSpectrum Asia spoke to Joseph Y. Chang, PhD, Chief Scientific Officer and Executive Vice President- Product Development, Nu Skin Enterprises. With over 35 years of experience in the pharmaceutical and dietary supplement industries, Dr Chang enjoys a comprehensive knowledge of both of these industries and serves as a member of the Executive Committee for Nu Skin Enterprises.
“The concept of anti-ageing should, therefore, include youth preservation as part of its objective”

Edited excerpts;

What are your views on the growth and challenges of the antiageing market in Asian countries?

With the success of medicine and new technologies, people are living longer. With the rate of ageing in Asian countries accelerating and exceeding the rate of ageing in the western world, the anti-ageing market in Asia will grow to around $120 billion by 2030. And skin care products that address skin ageing form a significant percentage of this market.

An integrated approach of modern and ancient medicine to beauty and wellness is attractive to consumers. But the holistic approach of ancient medicine system, for example Ayurveda medicine, does not have enough scientific understanding of the ingredients that are used in Ayurvedic medicine. In order to extract more value, a scientific evaluation could increase its appeal to a wider audience.

Whilst anti-ageing products have a strong appeal to an older population, younger consumers are more attracted to products that can preserve their youthfulness. This is likely to be a growing trend in the future. The concept of anti-ageing should, therefore, include youth preservation as part of its objective.

How do you foresee the intervention of science and technology in anti-aeging in the coming years?

Looking for the sources of ageing and identifying the cause of aging is vital. Intervening at an earlier point of aging will lead to a better outcome. More research and understanding of the overall expression of the genes, alongside identifying and targeting gene expression patterns, specific genes which influence aspects of ageing, is required.

هذه القصة مأخوذة من طبعة BioSpectrum Asia August 2022 من BioSpectrum Asia.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة BioSpectrum Asia August 2022 من BioSpectrum Asia.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.

المزيد من القصص من BIOSPECTRUM ASIA مشاهدة الكل
Australia invests $1.89B for health and medical research transformation
BioSpectrum Asia

Australia invests $1.89B for health and medical research transformation

The government is investing in a once in a generation transformation of health and medical research in Australia.

time-read
1 min  |
June 2024
NZ suggests new way to prevent rheumatic heart disease progression
BioSpectrum Asia

NZ suggests new way to prevent rheumatic heart disease progression

A new way of delivering treatment to prevent rheumatic heart disease progression is significantly less painful than an almost 70-year-old existing treatment, a University of Otago-led study in New Zealand (NZ) has found.

time-read
1 min  |
June 2024
WHO prequalifies Takeda's dengue vaccine
BioSpectrum Asia

WHO prequalifies Takeda's dengue vaccine

A new vaccine for dengue has received prequalification from the World Health Organization (WHO).

time-read
1 min  |
June 2024
GIBF invests $10M in Israel's Nectin Therapeutics to advance ADCs
BioSpectrum Asia

GIBF invests $10M in Israel's Nectin Therapeutics to advance ADCs

Guangzhou-Israel Biotechnology Fund (GIBF) has invested $10 million in Nectin Therapeutics.

time-read
1 min  |
June 2024
HOYA Group to distribute AIassisted lesion detection device in US
BioSpectrum Asia

HOYA Group to distribute AIassisted lesion detection device in US

Japan-based HOYA Group Company, PENTAX of America, Inc. (PENTAX Medical, a division of HOYA Group) and MAGENTIQ-EYE, an artificial intelligence (AI)-based medical device company, have announced their intention to form a partnership in the field of AI in gastroenterology and to examine further collaboration and strategic partnerships.

time-read
1 min  |
June 2024
Saudi Arabia pledges $500M to protect children from polio
BioSpectrum Asia

Saudi Arabia pledges $500M to protect children from polio

At the first-ever World Economic Forum (WEF) Special Meeting hosted in Riyadh recently, the Kingdom of Saudi Arabia has pledged $500 million over the next five years to support the work of the Global Polio Eradication Initiative (GPEI).

time-read
1 min  |
June 2024
Scientists explore use of COVID-19 variant vaccine against other coronaviruses
BioSpectrum Asia

Scientists explore use of COVID-19 variant vaccine against other coronaviruses

An international consortium of researchers developing a vaccine against troublesome COVID-19 variants will receive additional CEPI funding to investigate whether it could also protect against other deadly coronaviruses.

time-read
1 min  |
June 2024
How Thai Biotech is Thriving with Innovations
BioSpectrum Asia

How Thai Biotech is Thriving with Innovations

Thailand's biotech industry is rapidly evolving, positioning itself as a key player in the ASEAN regions and the global biotechnology landscape. With a strategic focus on research and development, supportive government policies and a burgeoning ecosystem of startups and research institutions, Thailand is emerging as a hotspot for biotech innovation in Southeast Asia.

time-read
2 mins  |
June 2024
Why multi-use real estate is in demand for life sciences companies
BioSpectrum Asia

Why multi-use real estate is in demand for life sciences companies

India's Biocon, Enzene Biosciences, and Meteoric Biopharmacueticals, Japan's Daiichi Sankyo, and Singapore's Hummingbird Bioscience, have all recently sought to lease, acquire, and set up shop in a mixed-use space in the US. And for those companies who wish to enter or expand in the US market, New Jersey is a top choice due to its existing infrastructure, cultural connections, robust talent and location.

time-read
4 mins  |
June 2024
"The dialogue surrounding pharmaceutical gowning is experiencing significant transformation in 2024 & beyond"
BioSpectrum Asia

"The dialogue surrounding pharmaceutical gowning is experiencing significant transformation in 2024 & beyond"

Finland-based Lindström, a leading global provider of workwear, cleanroom workwear, and mat services, is making significant strides in its expansion efforts, particularly in key markets such as India, China, Vietnam, and Turkey.

time-read
5 mins  |
June 2024